December 22, 2016
Brysen is a 16-year-old from New Jersey. He arrived at our clinic on December 5, 2016, for treatment of CRPS, which he developed following surgery for a closed wrist reduction one year ago. The pain was concentrated in his left leg and arm.
He had previously been prescribed a number of anticonvulsants medications for pain management, which were not successful.
When he arrived at our clinic in New Jersey, his pain level was at a 7/10 which had escalated to as high as a 10/10. He was also prescribed Amitriptyline.
Prior to coming to the Calmare NJ clinic, Brysen had completed an intensive physical therapy regime at the renowned Children’s Hospital of Philadelphia (CHOP).
The teenager underwent 10 daily treatments of scrambler therapy which lasted about 35-minutes each. By treatment number three, he began to realize a pain reduction in both his leg and arm. As the treatments continued, his pain level continued to plummet.
Brysen’s Patient Outcome After Calmare Therapy for Complex Regional Pain Syndrome
Tomorrow he will complete his final treatment, but as of today, he is pain-free.
Additionally, he is no longer taking any pain medication.
He and his family will be leaving shortly for a vacation in Hawaii.
We have a feeling this is going to be a very special Christmas for Brysen and his family.
Are You or a Loved One Battling RSD or CRPS?
Dr. Michael Cooney is known internationally for his success lessening or eliminating severe treatment-resident chronic pain using Calmare scrambler therapy. We are now booking 2017 consultations with the doctor by phone (there is no fee for this consultation).
If you would like to schedule a call with the doctor, first review all the pages of this website to learn more about how scrambler therapy works and how the painless treatments are performed.
Please know the treatment cycle requires you to visit the office for 10 visits over two weeks.
Our Calmare administrative team would be happy to offer recommendations for lodging nearby.
Please complete the eCard below, and we’ll be happy to follow-up with you: